Biotech Cluster News Today

Repurposing mirabegron, a drug used to treat overactive bladder disease, did not significantly change left ventricular mass index or diastolic function in pre–heart failure structural heart disease.

How new biotech clusters in smaller cities across the country are emerging and challenging market leaders like Boston, San Diego, and San Francisco.